Our understanding of the natural history of hepatitis B virus (HBV) infection and the potential
for therapy of the resultant disease has improved. Several new and effective antiviral agents …

The treatment of hepatitis C has dramatically improved over the past decade. Unlike any
other chronic viral infection, a significant proportion of patients with chronic hepatitis C can …

Our understanding of the natural history of hepatitis B virus (HBV) infection and the potential
for therapy of the resultant disease is continuously improving. New data have become …

Hepatitis C virus (HCV) infection is one of the main causes of chronic liver disease
worldwide. The long-term impact of HCV infection is highly variable, from minimal changes …

These guidelines have been written to assist physicians and other health care providers in
the recognition, diagnosis, and management of patients chronically infected with the …

Background Tenofovir disoproxil fumarate (DF) is a nucleotide analogue and a potent
inhibitor of human immunodeficiency virus type 1 reverse transcriptase and hepatitis B virus …

Chronic HBV infection is an important public health problem worldwide and in the United
States. A treatment algorithm for the management of this disease, published previously by a …

Most viral diseases, with the exception of those caused by human immunodeficiency virus,
are self-limited illnesses that do not require specific antiviral therapy. The currently available …

Persons at high risk for human immunodeficiency virus (HIV) infection are also likely to be at
risk for other infectious pathogens, including hepatitis B virus (HBV) or hepatitis C virus …

BACKGROUND/AIMS: We analyzed the characteristics of HIV infected patients who died
from liver disease, focusing on hepatitis virus co-infection. METHODS: One-hundred and …